Regeneron Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $439M | 456k | 962.49 |
| 2023-12-31 | $337M | 383k | 878.30 |
| 2023-09-30 | $277M | 336k | 822.96 |
| 2023-06-30 | $246M | 342k | 718.54 |
| 2023-03-31 | $243M | 296k | 821.66 |
| 2022-12-31 | $305M | 423k | 721.49 |
| 2022-09-30 | $227M | 330k | 686.27 |
| 2022-06-30 | $237M | 401k | 591.13 |
| 2022-03-31 | $256M | 358k | 714.29 |
| 2021-12-31 | $242M | 384k | 631.52 |
| 2021-09-30 | $203M | 335k | 605.19 |
| 2021-06-30 | $153M | 274k | 558.64 |
| 2021-03-31 | $126M | 266k | 473.14 |
| 2020-12-31 | $67M | 140k | 482.98 |
| 2020-09-30 | $46M | 82k | 559.78 |
| 2020-06-30 | $79M | 127k | 623.65 |
| 2020-03-31 | $47M | 96k | 488.29 |
| 2019-12-31 | $45M | 121k | 375.00 |
| 2019-09-30 | $40M | 141k | 280.00 |
| 2019-06-30 | $34M | 108k | 313.00 |
| 2019-03-31 | $84M | 201k | 420.00 |
| 2018-12-31 | $65M | 173k | 373.68 |
| 2018-09-30 | $81M | 200k | 404.16 |
| 2018-06-30 | $57M | 166k | 344.89 |
| 2018-03-31 | $55M | 160k | 344.26 |
| 2017-12-31 | $76M | 203k | 375.79 |
| 2017-09-30 | $61M | 136k | 447.13 |
| 2017-06-30 | $63M | 129k | 491.14 |
| 2017-03-31 | $38M | 99k | 387.52 |
| 2016-12-31 | $28M | 76k | 367.09 |
| 2016-09-30 | $25M | 63k | 402.03 |
| 2016-06-30 | $11M | 32k | 349.01 |
| 2016-03-31 | $11M | 30k | 360.54 |
| 2015-12-31 | $40M | 73k | 542.86 |
| 2015-09-30 | $26M | 56k | 465.00 |
| 2015-03-31 | $41M | 91k | 451.11 |